» Articles » PMID: 38136376

Relation Between Coronary Artery Calcium Score and Cardiovascular Events in Hodgkin Lymphoma Survivors: A Cross-Sectional Matched Cohort Study

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Dec 23
PMID 38136376
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Thoracic radiotherapy is one of the corner stones of HL treatment, but it is associated with increased risk of cardiovascular events. As HL is often diagnosed at a young age, long-term follow-up including screening for coronary artery disease (CAD) is recommended.

Objectives: This study aims to evaluate the presence of coronary artery calcium score (CACS) in relation to cardiovascular events in HL patients treated with thoracic radiotherapy compared to a non-cancer control group.

Methods: Consecutive HL patients who underwent evaluation for asymptomatic CAD with coronary computed tomography angiography > 10 years after thoracic irradiation were included. The study population consisted of 97 HL patients matched to 97 non-cancer patients on gender, age, cardiovascular risk factors, and statin use.

Results: Mean age during CT scan in the HL population was 45.5 ± 9.9 and in the non-cancer population 45.5 ± 10.3 years. CACS was elevated (defined as >0) in 49 (50.5%) HL patients and 30 (30.9%) control patients. HL survivors had an odds ratio of 2.28 [95% CI: 1.22-4.28] for having a CACS > 0 compared to the matched population ( = 0.006). Prevalence of CACS > 90th percentile differed significantly: 17.1% in HL survivors vs. 4.6% in the matched population ( 0.009). Non-obstructive coronary artery stenosis was more prevalent in the HL population than in the control population (45.7% vs. 28.4%, respectively, = 0.01). During follow-up of 8.5 [5.3; 9.9] years, nine HL patients experienced an event including two patients with a CACS of zero. No events occurred in the control population.

Conclusion: In a matched study population, HL survivors have a higher prevalence of a CACS > 0 and an increased risk of cardiovascular events after thoracic irradiation compared to a matched non-cancer control group.

Citing Articles

Radiation-associated cardiovascular disease in patients with cancer: current insights from a cardio-oncologist.

Uehara M, Bekki N, Shiga T J Radiat Res. 2024; 65(5):575-590.

PMID: 39256035 PMC: 11420984. DOI: 10.1093/jrr/rrae068.

References
1.
Honaryar M, Allodji R, Ferrieres J, Panh L, Locquet M, Jimenez G . Early Coronary Artery Calcification Progression over Two Years in Breast Cancer Patients Treated with Radiation Therapy: Association with Cardiac Exposure (BACCARAT Study). Cancers (Basel). 2022; 14(23). PMC: 9735519. DOI: 10.3390/cancers14235724. View

2.
Kupeli S, Hazirolan T, Varan A, Akata D, Alehan D, Hayran M . Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol. 2009; 28(6):1025-30. DOI: 10.1200/JCO.2009.25.2627. View

3.
Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138(20):e618-e651. DOI: 10.1161/CIR.0000000000000617. View

4.
Dalager M, Bottcher M, Thygesen J, Andersen G, Botker H . Different Plaque Composition and Progression in Patients with Stable and Unstable Coronary Syndromes Evaluated by Cardiac CT. Biomed Res Int. 2015; 2015:401357. PMC: 4538323. DOI: 10.1155/2015/401357. View

5.
Lancellotti P, Nkomo V, Badano L, Bergler-Klein J, Bogaert J, Davin L . Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013; 14(8):721-40. DOI: 10.1093/ehjci/jet123. View